10 insiders reported 31 Form 4 transactions for Aptevo Therapeutics Inc. (APVO) over the past 18 months (most recent 2026-08-10). Recent activity: Harsanyi Zsolt (Director) Buy 400 shares, Kunz Barbara Lopez (Director) Buy 400 shares, Taylor Daphne (SVP, CFO) Buy 638 shares, White Marvin L (Executive Chair) Buy 1 shares, Niederhuber John (Director) Buy 400 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Harsanyi Zsolt | Director | Buy | 400 | $0 |
| 2026-08-10 | Kunz Barbara Lopez | Director | Buy | 400 | $0 |
| 2026-08-10 | Taylor Daphne | SVP, CFO | Buy | 638 | $0 |
| 2026-08-10 | White Marvin L | Executive Chair | Buy | 1 | $0 |
| 2026-08-10 | Niederhuber John | Director | Buy | 400 | $0 |
| 2026-08-10 | Grant Grady III | Director | Buy | 400 | $0 |
| 2026-08-10 | Lamothe Jeffrey G. | President and CEO | Buy | 961 | $0 |
| 2026-08-10 | Abdun-Nabi Daniel | Director | Buy | 400 | $0 |
| 2026-08-10 | Huebner Dirk | SVP, CMO | Buy | 638 | $0 |
| 2026-08-10 | Kwon SoYoung | SVP, GC, BD & Corp Affairs | Buy | 638 | $0 |
| 2026-08-10 | White Marvin L | Executive Chair | Buy | 1,666 | $0 |
| 2026-08-10 | Huebner Dirk | SVP, CMO | Sell | 156 | $635 |
| 2026-08-10 | White Marvin L | Executive Chair | Sell | 406 | $1,652 |
| 2025-11-12 | Grant Grady III | Director | Buy | 13,513 | $20,134 |
| 2025-07-21 | Abdun-Nabi Daniel | Director | Buy | 1 | $0 |
| 2025-07-21 | Lamothe Jeffrey G. | EVP, COO | Buy | 5 | $0 |
| 2025-07-21 | White Marvin L | President and CEO | Buy | 10 | $0 |
| 2025-07-21 | Harsanyi Zsolt | Director | Buy | 1 | $0 |
| 2025-07-21 | Grant Grady III | Director | Buy | 1 | $0 |
| 2025-07-21 | Kwon SoYoung | SVP, GC, BD & Corp Affairs | Buy | 3 | $0 |
| 2025-07-21 | Taylor Daphne | SVP, CFO | Buy | 3 | $0 |
| 2025-07-21 | Niederhuber John | Director | Buy | 1 | $0 |
| 2025-07-21 | Kunz Barbara Lopez | Director | Buy | 1 | $0 |
| 2025-03-04 | Taylor Daphne | SVP, CFO | Buy | 1 | $0 |
| 2025-03-04 | Taylor Daphne | SVP, CFO | Buy | 2 | $0 |
Source: SEC Form 4 filings · as of 2026-08-10